Role of NQ01, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia

International Journal of Cancer

Volumn 97, Issue 2, 2002, Pages 230-236

  Krajinovic, Maja ^a   Sinnett, Hugues ^a   Richer, Chantal ^a   Labuda, Damian ^a,b   Sinnett, Daniel ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Acute lymphoblastic leukemia; Cancer genetics; Cytochrome P 450; Genetic polymorphism; Myeloperoxidase; Quinone oxidoreductase

Indexed keywords

CYTOCHROME P450 2E1; MYELOPEROXIDASE; OXIDOREDUCTASE; QUINONE DERIVATIVE; XENOBIOTIC AGENT; PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; CANADA; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; B CELL LEUKEMIA; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR; T CELL LEUKEMIA;

CASE-CONTROL STUDIES; CHILD; CYTOCHROME P-450 CYP2E1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKEMIA, PRE-B-CELL; LEUKEMIA, T-CELL, ACUTE; MALE; NAD(P)H DEHYDROGENASE (QUINONE); PEROXIDASE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0037049795     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1589     Document Type: Article

References (79)

1. Molecular epidemiology: Insight into cancer susceptibility, risk assessment, and prevention
2. Environment and cancer: Who are susceptible?
3. Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms
4. Genetic polymorphisms of N-acetyltransferase 1 (NAT1) and 2 (NAT2) and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia
5. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes
6. Oxidative and reductive metabolism by cytochrome P450 2E1
7. Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes
8. Detection and characterization of novel polymorphisms in the CYP2E1 gene
9. PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E1 gene
10. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region
11. Genetic polymorphisms in the 5′ flanking region change transcriptional regulation of the human cytochrome P450E1 gene
12. Hepatic messenger RNA contents of cytochrome P4502E1 in patients with different P4502E1 genotypes
13. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens
14. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer
15. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients
16. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1, environmental factors and risk of oral cancer
17. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan
18. Polymorphism of metabolizing genes and lung cancer histology: Prevalence of CYP2E1 in adenocarcinoma
19. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer
20. Rsal polymorphism at the cytochrome P4503E1 locus and risk of hepatocellular carcinoma
21. Susceptibility to esophageal cancer and genetic polymorphisms in gluthatione S-transferases T1, P1, and M1 and cytochromeP450 2E1
22. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County
23. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk
24. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population
25. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamouscell carcinoma of the esophagus
26. Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo-[a]pyrene-DNA adducts in lung tissue in vitro: A role of pulmonary inflammation in the bioactivation of a procarcinogen
27. Metabolic basis of benzene toxicity
28. Oxidation of hydroquinone by myeloperoxidase. Mechanism of stimulation by benzoquinone
29. Phagocytic killing of microorganisms by radical processes: Consequences of the reaction of hydroxyl radical with chloride yielding chlorine atoms
30. An Alu element in the myeloperoxidase promoter contains a composite SPl-thyroid hormone-retinoic acid response element
31. Myeloperoxidase genetic polymorphism and lung cancer risk
32. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia
33. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease
34. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis
35. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene
36. Nrf1 and Nrf2 positively and c-Fos and Fral negatively regulate the human antioxidant response element-mediated expression of NAD(P)H: Quinone oxidoreductasel gene
37. Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase)
38. NAD(P)H:Quinone oxidoreductase: Polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations
39. NAD(P)H:Quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells
40. Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:Quinone oxidoreductase (NQOI) gene in patients with primary and therapy-related myeloid leukemia
41. Increased frequency of a null-allele for NAD(P)H: Quinone oxidoreductase in patients with urological malignancies
42. 609 C → T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia
43. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:Quinone oxidoreductase polymorphism
44. Identification of an NAD(P)H:Quinone oxidoreductase polymorphism and its association with lung cancer and smoking
45. Detection of a point mutation in NQOI (DT-diaphorase) in a patient with colon cancer
46. Re: Detection of a point mutation in NQOI (DT-diaphorase) in a patient with colon cancer
47. Ethnic variation in the CYP2E1 gene: Polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese
48. Genetic susceptibility to childhood acute lymphoblastic leukemia
49. How many diseases does it take to map a gene with SNPs?
50. Allelic loss in childhood acute lymphoblastic leukemia
51. Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay
52. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes
53. Expression of cytochrome P4502E1 in human liver: Assessment by mRNA, genotype and phenotype
54. A lack of a functional NAD(P)H:Quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions
55. Association of NAD(P)H:quinone oxidoreductase (NQOI) null with numbers of basal cell carcinomas: Use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci
56. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: Identification of target cells and a potential role for modulation of apoptosis in benzene toxicity
57. Benzene, NQO1, and genetic susceptibility to cancer
58. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity
59. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone
60. Does lung NAD(P)H:quinone reductase (DT-diaphorase) play an antioxidant enzyme role in protection from hyperoxia?
61. The reduction of alpha-tocopherolquinone by human NAD(P)H: Quinone oxidoreductase: The role of alpha-tocopherolhydroquinone as a cellular antioxidant
62. Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells
63. Application of biologic markers to studies of environmental risks in children and the developing fetus
64. Alu-PCR combined with non-Alu primers reveals multiple polymorphic loci
65. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: Role in intrauterine toxicity
66. Detection of benzo[a]pyrene-DNA adducts in human placenta and umbilical cord blood
67. Modulatory effect of maternal serum on xenobiotic metabolizing activity of placental explants: Modification by cigarette smoking
68. DNA adducts in human placenta as related to air pollution and to GSTM1 genotype
69. Cytochrome P450 CYP1A1 enzyme activity and DNA adducts in placenta of women environmentally exposed to organochlorines
70. Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype
71. Epidemiology of the childhood acute leukemias
72. Descriptive epidemiology of childhood leukaemia
73. Childhood leukemia: Risk associated with exposure to pesticides and with gene polymorphisms
74. Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Quebec, Canada)
75. Expression of CYP2E1 in human lung and kidney during development and in full-term placenta: A differential methylation of the gene is involved in the regulation process
76. Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes
77. The first-appearance of neutrophils in the human fetal bone marrow cavity
78. Peroxidase activity in murine and human hematopoietic progenitor cells: Potential relevance to benzene-induced toxicity